| Dr Kemily Alexander Rankin, OD | |
|
314 Sgt Prentiss Dr, Natchez, MS 39120-4224 | |
| (601) 455-1155 | |
| (800) 948-4615 |
| Full Name | Dr Kemily Alexander Rankin |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 314 Sgt Prentiss Dr, Natchez, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649213471 | NPI | - | NPPES |
| 03458053 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 725 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kemily Alexander Rankin, OD 4223 I-20 Frontage Rd Apt J18, Vicksburg, MS 39183-3533 Ph: (601) 455-1155 | Dr Kemily Alexander Rankin, OD 314 Sgt Prentiss Dr, Natchez, MS 39120-4224 Ph: (601) 455-1155 |
News Archive
ResCare, Inc. announced today that it has entered into a definitive agreement with an entity sponsored by Onex Partners III, L.P. ("Onex"), an affiliate of Onex Corporation. Under the terms of the agreement, Onex would acquire all of the outstanding shares of ResCare common stock not owned by Onex affiliates or participating members of ResCare's management for $13.25 per share in cash, which represents a 30.7% premium to the closing price on August 13, 2010, the last trading day before Onex made its initial proposal.
Pre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major pathological responses in 100% of early-stage colon cancers with mismatch repair deficiencies, according to results reported at ESMO 2018 from the first exploratory phase II trial to investigate this approach.
"Healing" has become a buzzword in American culture. But what exactly does it mean? In his new book, Healing (Hawk Press, 2010), healer David Elliott defines healing as "the journey back to our natural state of balance and harmony that is called love."
Catalent Pharma Solutions, the leading provider of advanced oral drug delivery technologies to the pharmaceutical industry, has entered into a strategic alliance with Endotis Pharma for the development of oral formulations of synthetic oligosaccharides.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that Phase 1 data of perifosine (KRX-0401) in recurrent pediatric solid tumors was presented yesterday in the pediatric solid tumor poster discussion session held at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago.
› Verified 5 days ago
Harold A Jefcoat, O. D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 29 Sgt Prentiss Dr Ste 6, Natchez, MS 39120 Phone: 601-442-4354 | |
Doherty Vision Clinic Pa Optometrist Medicare: Medicare Enrolled Practice Location: 611 Franklin St, Natchez, MS 39120 Phone: 601-445-4282 Fax: 601-445-4266 | |
Dr. Shawn Paul Doherty, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 611 Franklin St, Natchez, MS 39120 Phone: 601-445-4282 | |
Rankin Eye Professionals Optometrist Medicare: Not Enrolled in Medicare Practice Location: 314 Sgt Prentiss Dr, Natchez, MS 39120 Phone: 601-455-1155 Fax: 800-948-4615 | |
Whitaker Eye Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 381 John R Junkin Dr, Natchez, MS 39120 Phone: 601-443-9876 | |
Dr. Patrick Rowan Doherty, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 611 Franklin St, Natchez, MS 39120 Phone: 601-445-4282 Fax: 601-445-9197 |